Skip to content
March 18, 2026
  • Ozempic Patent Expiry Set to Spark Cheaper Weight-Loss Drug Boom in India
  • World Bank Approves $300 Million Loan for Uttar Pradesh’s Clean Air Transition
  • AIIMS-Delhi Initiates India’s First Passive Euthanasia Process for Coma Patient
  • West Asia Conflict Dampens Medical Tourism to India, Patient Inflow Drops Sharply
tishha_logo

Tishha News

  • Home
  • News
  • Economics
  • Technology Innovations
  • Global Healthcare
  • Expert Talks
  • Web Stories
  • Home
  • Abhayrab

Abhayrab

image 10
  • News

Abhayrab Remains Safe When Sourced Through Authorised Channels, Says Indian Immunologicals

tishha_newsJanuary 10, 2026January 10, 202607 mins

Amid international advisories urging caution for travellers vaccinated against rabies in India due to reports of counterfeit vaccines, Indian Immunologicals…

Read More

Most Viewed

News
Ozempic Patent Expiry Set to Spark Cheaper Weight-Loss Drug Boom in India
The patent for semaglutide the key ingredient in Ozempic and…
News
World Bank Approves $300 Million Loan for Uttar Pradesh’s Clean Air Transition
The World Bank has approved a loan of about $300…

Random

1

Ozempic Patent Expiry Set to Spark Cheaper Weight-Loss Drug Boom in India

  • News
2

World Bank Approves $300 Million Loan for Uttar Pradesh’s Clean Air Transition

  • News
3

AIIMS-Delhi Initiates India’s First Passive Euthanasia Process for Coma Patient

  • News
4

West Asia Conflict Dampens Medical Tourism to India, Patient Inflow Drops Sharply

  • News
5

Climate Change May Push Millions Toward Inactivity by 2050: Lancet Study

  • News
6

10 Patients Die in Tragic Incident at SCB Medical College’s Trauma Care Centre in Cuttack

  • News
7

AMTZ Launches India’s First Dedicated Capital Fund for MedTech Start-ups

  • Market Watch
8

Sarvodaya Healthcare Takes Over Nayati Hospital in Mathura, Expands Capacity to 1,200 Beds

  • Merger and Acquisition
tishha_logo
TISHHA News Developed By BlazeThemes.